NCT03477435

Brief Summary

The investigators propose a Type I hybrid effectiveness/implementation study to evaluate two population-based approaches for increasing use of Quitlines and text messaging at two VA sites. Specifically, the investigators will test the default bias, examining whether an opt-out approach to referral is more effective than an opt-in approach. The investigators will randomly assign teams to either an opt-out or opt-in approach to referring smokers to treatment. In the opt-out approach, the default is that everyone is referred to treatment unless they actively choose not to be. In the opt-in approach, people are offered treatment but must actively choose to enroll in it.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,365

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2018

Completed
1.4 years until next milestone

Study Start

First participant enrolled

August 28, 2019

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

6.6 years

First QC Date

March 19, 2018

Last Update Submit

March 9, 2026

Conditions

Keywords

smokingtobacco dependencequitlinesmoking cessation

Outcome Measures

Primary Outcomes (3)

  • Proportion of smokers who accept referral to treatment (Quitline or text messaging)

    This outcome will be based on intervention process data. Note that we will measure both offering and accepting referral, but our outcome will be accepting referral.

    2-year intervention period

  • Proportion of smokers who engage in treatment with the Quitline or text messaging service

    This outcome will be based on data from the Quitline and SmokefreeTXT.

    2-year intervention period

  • Abstinence at the end of the 2-year intervention period

    Abstinence will be based on self-report, as is recommended for population-level studies

    7-day abstinence

Secondary Outcomes (2)

  • Cost-effectiveness of the two approaches (opt-out vs opt-in)

    2-year intervention period

  • Use of smoking cessation medications

    2-year intervention period

Study Arms (2)

Opt-in clinical reminder

EXPERIMENTAL

As the investigators have done previously, the reminder will be self-explanatory, and will walk staff through each step of referral. The reminder will include the following domains: normative advice, referral to treatment, handout

Behavioral: Staff training and academic detailing

Opt-out tobacco treatment

EXPERIMENTAL

The investigators will directly change the treatment status quo by implementing a clinical reminder that automatically initiates tobacco treatment referral at the time the reminder is activated.

Behavioral: Staff training and academic detailing

Interventions

Both arms will receive training at baseline to help their patients quit smoking. The training will be a mix of content and process education. We will provide brief updates to staff every 6 months throughout the intervention period, which will focus primarily on process education. We will monitor which staff attend and reach out separately to staff who did not. During the month after implementation of the clinical reminders, two study investigators will make a brief outreach visit to each staff member. We will follow a script, using the seven steps recommended by the National Resource Center for Academic Detailing: 1) Introduction; 2) Needs Assessment; 3) Key Messages/Features/Benefits; 4) Understanding Barriers and Enablers; 5) Identifying and Handling Objections; 6) Summary; and 7) Close. The key message (Step 3) will include demonstration of the clinical reminder, review of the evidence for telephone counseling and text messaging and how to refer patients.

Opt-in clinical reminderOpt-out tobacco treatment

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Survey Cohort -- Have been seen by an NA on the PACT team in the past 12 months at the Manhattan or Brooklyn VA campus AND Current smoker
  • Nursing Assistants/Registered Nurses -- Work on a PACT at the Manhattan or Brooklyn VA campus
  • Administrative Cohort -- Have been seen by a PACT team at the Manhattan or Brooklyn VA campus AND Current smoker
  • Patient Post-Visit Survey Population -- Had a visit with an NA/RN included in the study AND Current smoker

You may not qualify if:

  • Survey Cohort -- Non-English speaking
  • Nursing Assistants/Registered Nurses -- None
  • Administrative Cohort -- None
  • Patient Post-Visit Survey Population -- Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA NY Harbor Healthcare System, New York, NY

New York, New York, 10010-5011, United States

Location

Related Publications (1)

  • Haber Y, Fu SS, Rogers E, Richter K, Tenner C, Dognin J, Goldfeld K, Gold HT, Sherman SE. A novel opt-in vs opt-out approach to referral-based treatment of tobacco use in Veterans Affairs (VA) primary care clinics: A provider-level randomized controlled trial protocol. Contemp Clin Trials. 2022 May;116:106716. doi: 10.1016/j.cct.2022.106716. Epub 2022 Mar 8.

MeSH Terms

Conditions

Tobacco UseSmokingTobacco Use DisorderSmoking Cessation

Condition Hierarchy (Ancestors)

BehaviorSubstance-Related DisordersChemically-Induced DisordersMental DisordersHealth Behavior

Study Officials

  • Scott E. Sherman, MD MPH

    VA NY Harbor Healthcare System, New York, NY

    PRINCIPAL INVESTIGATOR
  • Steven S. Fu, MD MSCE

    Minneapolis VA Health Care System, Minneapolis, MN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Type 1 hybrid effectiveness/implementation study to evaluate two population-based approaches
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2018

First Posted

March 26, 2018

Study Start

August 28, 2019

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations